• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障破坏在脑肿瘤治疗中的应用

Blood-brain barrier disruption in the treatment of brain tumors.

作者信息

Blanchette Marie, Fortin David

机构信息

Department of Neurosurgery, University of Sherbrooke Hospital, Sherbrooke, QC, Canada.

出版信息

Methods Mol Biol. 2011;686:447-63. doi: 10.1007/978-1-60761-938-3_23.

DOI:10.1007/978-1-60761-938-3_23
PMID:21082387
Abstract

Standard chemotherapy administered systemically has a limited efficacy in the treatment of brain tumors. One of the major obstacles in the treatment of brain neoplasias is the impediment to delivery across the intact blood-brain barrier (BBB). Many innovative approaches have been developed to circumvent this obstacle. One such strategy is BBB disruption (BBBD), which successfully increases the delivery of antineoplastic agents to the central nervous system (CNS). This chapter describes the application of the BBBD technique in rats. Different methods to evaluate and measure BBB permeability following hyperosmolar mannitol infusion including Evans blue staining, albumin immunohistochemistry, and dynamic magnetic resonance imaging are also described.

摘要

全身给予的标准化疗在脑肿瘤治疗中的疗效有限。治疗脑肿瘤的主要障碍之一是完整血脑屏障(BBB)对药物递送的阻碍。人们已经开发出许多创新方法来克服这一障碍。一种这样的策略是血脑屏障破坏(BBBD),它成功地增加了抗肿瘤药物向中枢神经系统(CNS)的递送。本章描述了BBBD技术在大鼠中的应用。还介绍了在高渗甘露醇输注后评估和测量血脑屏障通透性的不同方法,包括伊文思蓝染色、白蛋白免疫组织化学和动态磁共振成像。

相似文献

1
Blood-brain barrier disruption in the treatment of brain tumors.血脑屏障破坏在脑肿瘤治疗中的应用
Methods Mol Biol. 2011;686:447-63. doi: 10.1007/978-1-60761-938-3_23.
2
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.通过动脉内输注和破坏血脑屏障增强恶性脑肿瘤的化疗给药:舍布鲁克的经验。
Cancer. 2005 Jun 15;103(12):2606-15. doi: 10.1002/cncr.21112.
3
Osmotic blood-brain barrier modification for the treatment of malignant brain tumors.用于治疗恶性脑肿瘤的渗透性血脑屏障修饰
Clin J Oncol Nurs. 2004 Jun;8(3):263-7. doi: 10.1188/04.CJON.263-267.
4
Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.依托泊苷诱导大鼠血脑屏障破坏:开放持续时间及组织学后遗症
Cancer Res. 1986 Mar;46(3):1453-7.
5
Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.在 F98 神经胶质瘤大鼠模型中,使用激肽 B2 受体激动剂 [Phe(8)psi(CH(2)NH)Arg(9)]-BK 选择性打开肿瘤血脑屏障:一项 MRI 研究。
Neuropeptides. 2010 Apr;44(2):177-85. doi: 10.1016/j.npep.2009.12.009. Epub 2010 Jan 18.
6
A new method of quantitatively assessing the opening of the blood-brain barrier in murine animal models.一种定量评估小鼠动物模型血脑屏障通透性的新方法。
J Neurosci Methods. 2012 Jun 15;207(2):125-9. doi: 10.1016/j.jneumeth.2012.03.012. Epub 2012 Apr 12.
7
Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.甘露醇对血脑屏障的开放作用:蔗糖通透性存在区域差异,但⁸⁶Rb⁺或白蛋白的通透性无区域差异。
Brain Res. 2004 Jul 16;1014(1-2):221-7. doi: 10.1016/j.brainres.2004.04.034.
8
Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.在正常Wistar大鼠中使用磁共振成像对渗透破坏血脑屏障过程中的钆二乙烯三胺五乙酸进行实时监测。
Neurosurgery. 2009 Aug;65(2):344-50; discussion 350-1. doi: 10.1227/01.NEU.0000349762.17256.9E.
9
Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?肿瘤学中血脑屏障的调节:治疗脑肿瘤的治疗机会?
Cancer Treat Rev. 2004 Aug;30(5):415-23. doi: 10.1016/j.ctrv.2004.04.001.
10
Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine.经颈动脉注入长春瑞滨后血脑屏障通透性的改变
Anticancer Res. 1995 Nov-Dec;15(6B):2593-6.

引用本文的文献

1
Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review.纳米材料作为克服血脑屏障的药物递送剂:综述
ADMET DMPK. 2023 Oct 31;12(1):63-105. doi: 10.5599/admet.2043. eCollection 2024.
2
Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises.用于脑癌诊疗的智能纳米制剂:挑战与前景
Cancers (Basel). 2022 Nov 1;14(21):5389. doi: 10.3390/cancers14215389.
3
Applications of Focused Ultrasound for the Treatment of Glioblastoma: A New Frontier.聚焦超声在胶质母细胞瘤治疗中的应用:一个新领域。
Cancers (Basel). 2022 Oct 8;14(19):4920. doi: 10.3390/cancers14194920.
4
Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology.穿越血脑屏障:神经肿瘤学中用于药物递释的纳米颗粒技术的进展。
Int J Mol Sci. 2022 Apr 9;23(8):4153. doi: 10.3390/ijms23084153.
5
Recent Advances in RNA Therapy and Its Carriers to Treat the Single-Gene Neurological Disorders.RNA疗法及其载体治疗单基因神经疾病的最新进展
Biomedicines. 2022 Jan 12;10(1):158. doi: 10.3390/biomedicines10010158.
6
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB.固体脂质纳米粒(SLNs):一种通过血脑屏障靶向脑部的先进药物递送系统。
Pharmaceutics. 2021 Jul 31;13(8):1183. doi: 10.3390/pharmaceutics13081183.
7
Insights into Multifunctional Nanoparticle-Based Drug Delivery Systems for Glioblastoma Treatment.用于胶质母细胞瘤治疗的多功能纳米颗粒药物递送系统的见解
Molecules. 2021 Apr 14;26(8):2262. doi: 10.3390/molecules26082262.
8
Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors.免疫刺激型二氧化硅纳米颗粒增强脑肿瘤中的固有免疫。
Nanoscale Horiz. 2021 Feb 1;6(2):156-167. doi: 10.1039/d0nh00446d. Epub 2021 Jan 5.
9
Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology.适配体:新型疗法及其在神经肿瘤学中的潜在作用。
Cancers (Basel). 2020 Oct 9;12(10):2889. doi: 10.3390/cancers12102889.
10
Key for crossing the BBB with nanoparticles: the rational design.纳米颗粒穿越血脑屏障的关键:合理设计。
Beilstein J Nanotechnol. 2020 Jun 4;11:866-883. doi: 10.3762/bjnano.11.72. eCollection 2020.